FDA approves EUA for Moderna COVID-19 vaccine

FDA has reported that following their positive advisory committee meeting on Thursday regarding the Moderna COVID-19 vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization.

The agency has also notified the U.S. Centers for Disease Control and Prevention and Operation Warp Speed, so they can execute their plans for timely vaccine distribution.

Read the original statement.

More COVID-19 coverage HERE.